PARP3 and breast carcinoma: In addition, we have demonstrated that SETD2, BAP1, PBRM1 and PARP-3 are all down-regulated in the breast cancer cell line 21NT when compared to normal cells (HMEC), making them prime targets for tumour suppression / telomerase repression in breast cancer.